Notice of Two-Year Continuation of Disease Management Demonstration Project for TRICARE Standard Beneficiaries, 12081-12082 [2011-4865]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices
suited for care by the PCM or in an
urgent care setting.
b. Implementation
This demonstration will be effective
60 days from the date of this notice for
a period of twenty-four (24) months.
c. Evaluation
The results of this Demonstration will
allow a focused study of the impact of
this process on: (1) The reduction of ER
utilization and resulting costs, (2)
assessment of the availability and
accessibility of less expensive acute care
services such as UCCs, (3) reduction of
administrative processes, and (4) impact
on Coast Guard active duty service
members and their families. The
evaluation/analysis of the
demonstration would use Fiscal Year
2008 as the base line with follow-up
data analysis conducted at each 6month interval throughout the 24 month
period to monitor of ER and TRICARE
authorized UCC utilization workload
and cost (claims data). Success of the
demonstration would be determined by
consistent shifts in health care
utilization from ERs to a TRICARE
authorized UCCs by 15–20%. A less
than 5% shift in utilization from the ER
to a TRICARE authorized UCCs would
be considered insignificant.
Dated: March 1, 2011.
Morgan F. Park,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2011–4863 Filed 3–3–11; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Notice of Two-Year Continuation of
Disease Management Demonstration
Project for TRICARE Standard
Beneficiaries
Department of Defense.
ACTION: Notice of Two-Year
Continuation of Disease Management
Demonstration Project for TRICARE
Standard Beneficiaries.
AGENCY:
This notice is to advise
interested parties of the continuation of
a Military Health System (MHS)
demonstration project entitled ‘‘Disease
Management Demonstration Project for
TRICARE Standard Beneficiaries’’. The
original demonstration notice was
published on June 13, 2007 (72 FR
32628–32629) and described a
demonstration project to provide
disease management (DM) services to
TRICARE Standard beneficiaries in
jlentini on DSKJ8SOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
19:16 Mar 03, 2011
Jkt 223001
addition to the TRICARE Prime
beneficiaries who were already entitled
to such services. TRICARE began the
demonstration project in March 2007 for
Standard beneficiaries and this
demonstration project has enabled the
MHS to provide uniform policies and
practices on disease and chronic care
management throughout the TRICARE
network. Additionally, the
demonstration has helped determine the
effectiveness of DM programs in
improving the health status of
beneficiaries with targeted chronic
diseases or conditions, and any
associated cost savings. The TRICARE
Management Activity (TMA) chose a
phased approach to determine the
efficacy and cost effectiveness of its
disease management demonstration,
beginning with beneficiaries identified
with the disease states of asthma, heart
failure, and diabetes. TMA now intends
to continue the disease management
services to TRICARE Standard
beneficiaries until a permanent
TRICARE disease management benefit
(per the John Warner National Defense
Authorization Act of 2007, section 734)
is implemented. This continuation of
the disease management demonstration
project will be conducted under the
authority provided in 10 U.S.C. 1092.
DATES: Effective date: The extension of
the demonstration will be effective
April 1, 2011 and will continue for a
period of two years until March 31,
2013.
ADDRESSES: TRICARE Management
Activity (TMA), 5111 Leesburg Pike,
Suite 810, Falls Church, VA 22041–
3206.
FOR FURTHER INFORMATION CONTACT:
Robin Marzullo, Disease Management
Nurse Consultant, Population Health
and Medical Management—TRICARE
Management Activity, telephone (703)
681–6717 x 1214.
SUPPLEMENTARY INFORMATION:
A. Background
For additional information on the
TRICARE demonstration project for
disease management, please see 72 FR
32628–32629 and 74 FR 11089–11090.
The original demonstration notice
focused on explaining the differences
between the disease management
benefits available to TRICARE Standard
and TRICARE Prime beneficiaries and
the manner in which disease
management services had been provided
prior to the demonstration. The prior
notice explained that for purposes of the
demonstration, the Department of
Defense (DoD) would waive, for these
disease management services provided
to Standard beneficiaries, the provisions
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
12081
of 10 U.S.C. 1079(a)(13) and 32 CFR
199.4(g)(39) that expressly exclude
clinical preventive services for
TRICARE Standard beneficiaries. The
prior notice also explained the
enrollment process and cap on disease
management costs.
B. Description of Extension of
Demonstration Project
Under this demonstration, DoD has
waived, for disease management
services provided to TRICARE Standard
beneficiaries, the provisions of 10 U.S.C.
1079(a)(13) and 32 CFR 199.4(g)(39) that
expressly exclude clinical preventive
services for TRICARE Standard
beneficiaries in the current benefit. The
Military Health System (MHS) has
enrolled TRICARE Standard
beneficiaries in its disease management
programs. Disease management services
provided to Standard beneficiaries have
included, but have not been limited to:
Clinical preventive examinations,
patient education and counseling
services, and periodic screening exams.
MHS disease management program
costs have been capped not to exceed
the amount approved by the contracting
officer. The disease management
program costs are total costs of disease
management services provided to both
Prime and Standard beneficiaries. Only
those beneficiaries identified by the
TRICARE Management Activity (TMA)
for disease management of asthma, heart
failure, diabetes, COPD, depression,
anxiety, and cancer, have been included
in the current program. Beneficiaries
identified by TMA are included in the
disease management program unless
they choose to opt out. This action
directly reduces variation across the
system and results in improved
consistency and quality for beneficiaries
with targeted chronic illness, regardless
of TRICARE classification. Furthermore,
including TRICARE Standard
beneficiaries in current disease
management efforts informs the MHS
about total potential savings and return
on investment (ROI) associated with
disease management, a stated
requirement of the John Warner
National Defense Authorization Act for
Fiscal Year 2007. Continuing to provide
disease management services to all
TRICARE beneficiaries will continue to
maintain our overall quality of care
throughout the MHS program. By
educating patients about their disease
and helping them manage their
symptoms, many of the complications of
these diseases can be avoided, possibly
slowing the progression of their chronic
disease, thus resulting in significant cost
savings.
E:\FR\FM\04MRN1.SGM
04MRN1
12082
Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices
C. Implementation
The extension of the demonstration
will be effective on April 1, 2011. The
terms and conditions of the original
demonstration as provided in the Notice
published at 72 FR 32368–32369 will
continue on that date.
D. Evaluation
An independent evaluation of the
demonstration will continue to be
conducted. The evaluation is designed
to use a combination of administrative
and survey measures of health care
outcomes (clinical, utilization, financial,
and humanistic measures) to provide
analyses and comment on meeting its
goal of providing uniform disease
management policies and practices
across the MHS.
Dated: March 1, 2011.
Morgan F. Park,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2011–4865 Filed 3–3–11; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
[Docket ID DOD–2011–OS–0028]
U.S. Court of Appeals for the Armed
Forces Proposed Rules Changes
Department of Defense.
Notice of Proposed Changes to
the Rules of Practice and Procedure of
the United States Court of Appeals for
the Armed Forces.
AGENCY:
ACTION:
This notice announces the
following proposed changes to Rules
9(e) and 41(b) of the Rules of Practice
and Procedure, United States Court of
Appeals for the Armed Forces.
DATES: Comments on the proposed
change must be received within 30 days
of the date of this notice.
ADDRESSES: You may submit comments,
identified by docket number and/or
Regulatory Information Number (RIN)
and title by any of the following
methods:
• Federal eRulemaking Portal:
https://www.regulations.gov.
• Mail: Federal Docket Management
System Office, 1160 Defense Pentagon,
OSD Mailroom 3C843, Washington, DC
20301–1160.
Instructions: All submissions received
must include the agency name and
docket number for this Federal Register
document. The general policy for
comments and other submissions from
members of the public is to make these
submissions available for public
jlentini on DSKJ8SOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
19:16 Mar 03, 2011
Jkt 223001
viewing on the Internet at https://
www.regulations.gov as they are
received without change, including
personal identifiers or contact
information.
FOR FURTHER INFORMATION CONTACT:
William A. DeCicco, Clerk of the Court,
telephone (202) 761–1448.
Dated: March 1, 2011.
Morgan F. Park,
Alternate OSD Federal Liaison Officer,
Department of Defense.
Rule 9(e)
Rule 9(e) currently reads:
(e) Hours. The Clerk’s office shall be
open for the filing of pleadings and
other papers from 8 a.m. to 5 p.m. every
day except Saturdays, Sundays, and
legal holidays, or as otherwise ordered
by the Court. See Rule 36(a). The Court
is always open for filing of pleadings
and other papers. A pleading or other
paper may be filed outside of normal
operating hours of the Clerk’s office by
delivery to the U.S. Marshal on duty in
the front lobby of the courthouse.
Pleadings will be deemed filed on the
date and time delivered to the U.S.
Marshal. The U.S. Marshal will notify
the Clerk of the filing in accordance
with procedures provided by the Clerk.
The proposed change to Rule 9(e)
would read:
(e) Hours. The Clerk’s office shall be
open for the filing of pleadings and
other papers from 8 a.m. to 5 p.m. every
day except Saturdays, Sundays, and
legal holidays, or as otherwise ordered
by the Court. See Rule 36(a). The Court
is always open for filing of pleadings
and other papers. A pleading or other
paper may be filed outside of normal
operating hours of the Clerk’s office by
delivery to Court security personnel on
duty in the front lobby of the
courthouse. Pleadings will be deemed
filed on the date and time delivered to
Court security personnel. Court security
personnel will notify the Clerk of the
filing in accordance with procedures
provided by the Clerk.
Comment: The proposed change
modifies the term ‘‘U.S. Marshal’’ in
three places to ‘‘Court security
personnel.’’ The reason for the change is
that security for the Court is now
provided by the Pentagon Force
Protection Agency, and not the U.S.
Marshals Service. The change will
therefore more accurately describe the
officers on duty.
Rule 41(b)
Rule 41(b) currently reads:
(a) The photographing, televising,
recording, or broadcasting of any
session of the Court or other activity
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
relating thereto is prohibited unless
authorized by the Court.
(b) Any violation of this rule will be
deemed a contempt of this Court and,
after due notice and hearing, may be
punished accordingly. See 18 U.S.C.
401.
The proposed change to Rule 41(b)
would read:
(a) The photographing, televising,
recording, or broadcasting of any
session of the Court or other activity
relating thereto is prohibited unless
authorized by the Court.
(b) Any violation of this rule will be
deemed a contempt of this Court and,
after due notice and hearing, may be
punished accordingly. See Article 48,
UCMJ.
Comment: In the recent National
Defense Authorization Act, Congress
amended Article 48, Uniform Code of
Military Justice, to give express
contempt power to the United States
Court of Appeals for the Armed Forces.
The proposed change reflects this direct
grant of authority to the Court.
[FR Doc. 2011–4927 Filed 3–3–11; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Department of the Air Force
[Docket ID USAF–2011–0007]
Privacy Act of 1974; System of
Records
AGENCY:
Department of the Air Force,
DoD.
Notice To Add a System of
Records.
ACTION:
The Department of the Air
Force proposes to add a system of
records to its inventory of record
systems subject to the Privacy Act of
1974 (5 U.S.C. 552a), as amended.
DATES: This proposed action will be
effective without further notice on April
4, 2011 unless comments are received
which result in a contrary
determination.
SUMMARY:
You may submit comments,
identified by docket number and/RIN
number and title, by any of the
following methods:
* Federal Rulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
* Mail: Federal Docket Management
System Office, 1160 Defense Pentagon,
OSD Mailroom 3C843, Washington, DC
20301–1160.
Instructions: All submissions received
must include the agency name and
docket number or Regulatory
ADDRESSES:
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 76, Number 43 (Friday, March 4, 2011)]
[Notices]
[Pages 12081-12082]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4865]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Notice of Two-Year Continuation of Disease Management
Demonstration Project for TRICARE Standard Beneficiaries
AGENCY: Department of Defense.
ACTION: Notice of Two-Year Continuation of Disease Management
Demonstration Project for TRICARE Standard Beneficiaries.
-----------------------------------------------------------------------
SUMMARY: This notice is to advise interested parties of the
continuation of a Military Health System (MHS) demonstration project
entitled ``Disease Management Demonstration Project for TRICARE
Standard Beneficiaries''. The original demonstration notice was
published on June 13, 2007 (72 FR 32628-32629) and described a
demonstration project to provide disease management (DM) services to
TRICARE Standard beneficiaries in addition to the TRICARE Prime
beneficiaries who were already entitled to such services. TRICARE began
the demonstration project in March 2007 for Standard beneficiaries and
this demonstration project has enabled the MHS to provide uniform
policies and practices on disease and chronic care management
throughout the TRICARE network. Additionally, the demonstration has
helped determine the effectiveness of DM programs in improving the
health status of beneficiaries with targeted chronic diseases or
conditions, and any associated cost savings. The TRICARE Management
Activity (TMA) chose a phased approach to determine the efficacy and
cost effectiveness of its disease management demonstration, beginning
with beneficiaries identified with the disease states of asthma, heart
failure, and diabetes. TMA now intends to continue the disease
management services to TRICARE Standard beneficiaries until a permanent
TRICARE disease management benefit (per the John Warner National
Defense Authorization Act of 2007, section 734) is implemented. This
continuation of the disease management demonstration project will be
conducted under the authority provided in 10 U.S.C. 1092.
DATES: Effective date: The extension of the demonstration will be
effective April 1, 2011 and will continue for a period of two years
until March 31, 2013.
ADDRESSES: TRICARE Management Activity (TMA), 5111 Leesburg Pike, Suite
810, Falls Church, VA 22041-3206.
FOR FURTHER INFORMATION CONTACT: Robin Marzullo, Disease Management
Nurse Consultant, Population Health and Medical Management--TRICARE
Management Activity, telephone (703) 681-6717 x 1214.
SUPPLEMENTARY INFORMATION:
A. Background
For additional information on the TRICARE demonstration project for
disease management, please see 72 FR 32628-32629 and 74 FR 11089-11090.
The original demonstration notice focused on explaining the differences
between the disease management benefits available to TRICARE Standard
and TRICARE Prime beneficiaries and the manner in which disease
management services had been provided prior to the demonstration. The
prior notice explained that for purposes of the demonstration, the
Department of Defense (DoD) would waive, for these disease management
services provided to Standard beneficiaries, the provisions of 10
U.S.C. 1079(a)(13) and 32 CFR 199.4(g)(39) that expressly exclude
clinical preventive services for TRICARE Standard beneficiaries. The
prior notice also explained the enrollment process and cap on disease
management costs.
B. Description of Extension of Demonstration Project
Under this demonstration, DoD has waived, for disease management
services provided to TRICARE Standard beneficiaries, the provisions of
10 U.S.C. 1079(a)(13) and 32 CFR 199.4(g)(39) that expressly exclude
clinical preventive services for TRICARE Standard beneficiaries in the
current benefit. The Military Health System (MHS) has enrolled TRICARE
Standard beneficiaries in its disease management programs. Disease
management services provided to Standard beneficiaries have included,
but have not been limited to: Clinical preventive examinations, patient
education and counseling services, and periodic screening exams. MHS
disease management program costs have been capped not to exceed the
amount approved by the contracting officer. The disease management
program costs are total costs of disease management services provided
to both Prime and Standard beneficiaries. Only those beneficiaries
identified by the TRICARE Management Activity (TMA) for disease
management of asthma, heart failure, diabetes, COPD, depression,
anxiety, and cancer, have been included in the current program.
Beneficiaries identified by TMA are included in the disease management
program unless they choose to opt out. This action directly reduces
variation across the system and results in improved consistency and
quality for beneficiaries with targeted chronic illness, regardless of
TRICARE classification. Furthermore, including TRICARE Standard
beneficiaries in current disease management efforts informs the MHS
about total potential savings and return on investment (ROI) associated
with disease management, a stated requirement of the John Warner
National Defense Authorization Act for Fiscal Year 2007. Continuing to
provide disease management services to all TRICARE beneficiaries will
continue to maintain our overall quality of care throughout the MHS
program. By educating patients about their disease and helping them
manage their symptoms, many of the complications of these diseases can
be avoided, possibly slowing the progression of their chronic disease,
thus resulting in significant cost savings.
[[Page 12082]]
C. Implementation
The extension of the demonstration will be effective on April 1,
2011. The terms and conditions of the original demonstration as
provided in the Notice published at 72 FR 32368-32369 will continue on
that date.
D. Evaluation
An independent evaluation of the demonstration will continue to be
conducted. The evaluation is designed to use a combination of
administrative and survey measures of health care outcomes (clinical,
utilization, financial, and humanistic measures) to provide analyses
and comment on meeting its goal of providing uniform disease management
policies and practices across the MHS.
Dated: March 1, 2011.
Morgan F. Park,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2011-4865 Filed 3-3-11; 8:45 am]
BILLING CODE 5001-06-P
